nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CYP3A4—Ezetimibe—atherosclerosis	0.0351	0.211	CbGbCtD
Phenoxybenzamine—CYP3A4—Rosuvastatin—atherosclerosis	0.0351	0.211	CbGbCtD
Phenoxybenzamine—CYP3A4—Simvastatin—atherosclerosis	0.0326	0.196	CbGbCtD
Phenoxybenzamine—CYP3A4—Pravastatin—atherosclerosis	0.0319	0.192	CbGbCtD
Phenoxybenzamine—CYP3A4—Lovastatin—atherosclerosis	0.0319	0.192	CbGbCtD
Phenoxybenzamine—Antazoline—HRH1—atherosclerosis	0.00517	0.149	CrCbGaD
Phenoxybenzamine—Pheniramine—HRH1—atherosclerosis	0.0043	0.124	CrCbGaD
Phenoxybenzamine—Clofedanol—HRH1—atherosclerosis	0.00392	0.113	CrCbGaD
Phenoxybenzamine—CALM2—artery—atherosclerosis	0.00372	0.0829	CbGeAlD
Phenoxybenzamine—CALM1—artery—atherosclerosis	0.0037	0.0825	CbGeAlD
Phenoxybenzamine—Diphenylpyraline—HRH1—atherosclerosis	0.00341	0.0981	CrCbGaD
Phenoxybenzamine—Tripelennamine—HRH1—atherosclerosis	0.00341	0.0981	CrCbGaD
Phenoxybenzamine—CALM2—endothelium—atherosclerosis	0.00314	0.0701	CbGeAlD
Phenoxybenzamine—CALM1—endothelium—atherosclerosis	0.00313	0.0697	CbGeAlD
Phenoxybenzamine—CALM2—blood vessel—atherosclerosis	0.0029	0.0646	CbGeAlD
Phenoxybenzamine—CALM1—blood vessel—atherosclerosis	0.00288	0.0643	CbGeAlD
Phenoxybenzamine—Cyclizine—HRH1—atherosclerosis	0.00274	0.0789	CrCbGaD
Phenoxybenzamine—Ospemifene—ESR1—atherosclerosis	0.00208	0.06	CrCbGaD
Phenoxybenzamine—SLC22A3—connective tissue—atherosclerosis	0.00175	0.039	CbGeAlD
Phenoxybenzamine—Toremifene—ESR1—atherosclerosis	0.0017	0.0489	CrCbGaD
Phenoxybenzamine—CALM2—connective tissue—atherosclerosis	0.00149	0.0331	CbGeAlD
Phenoxybenzamine—CALM1—connective tissue—atherosclerosis	0.00148	0.033	CbGeAlD
Phenoxybenzamine—Clomifene—ESR1—atherosclerosis	0.00147	0.0423	CrCbGaD
Phenoxybenzamine—CALM3—adipose tissue—atherosclerosis	0.00145	0.0324	CbGeAlD
Phenoxybenzamine—SLC22A1—adipose tissue—atherosclerosis	0.0014	0.0313	CbGeAlD
Phenoxybenzamine—Diphenhydramine—HRH1—atherosclerosis	0.00134	0.0387	CrCbGaD
Phenoxybenzamine—SLC22A3—adipose tissue—atherosclerosis	0.00134	0.0299	CbGeAlD
Phenoxybenzamine—CALM2—cardiovascular system—atherosclerosis	0.00129	0.0288	CbGeAlD
Phenoxybenzamine—CALM1—cardiovascular system—atherosclerosis	0.00129	0.0287	CbGeAlD
Phenoxybenzamine—Orphenadrine—HRH1—atherosclerosis	0.00127	0.0366	CrCbGaD
Phenoxybenzamine—ADRA1A—cardiovascular system—atherosclerosis	0.00121	0.027	CbGeAlD
Phenoxybenzamine—CALM2—adipose tissue—atherosclerosis	0.00114	0.0254	CbGeAlD
Phenoxybenzamine—CALM1—adipose tissue—atherosclerosis	0.00113	0.0253	CbGeAlD
Phenoxybenzamine—Tamoxifen—ESR2—atherosclerosis	0.0011	0.0317	CrCbGaD
Phenoxybenzamine—ADRA1A—adipose tissue—atherosclerosis	0.00107	0.0238	CbGeAlD
Phenoxybenzamine—ADRA2A—connective tissue—atherosclerosis	0.00106	0.0236	CbGeAlD
Phenoxybenzamine—ADRA2C—adipose tissue—atherosclerosis	0.00102	0.0227	CbGeAlD
Phenoxybenzamine—CALM3—liver—atherosclerosis	0.00102	0.0227	CbGeAlD
Phenoxybenzamine—SLC22A1—liver—atherosclerosis	0.000985	0.022	CbGeAlD
Phenoxybenzamine—SLC22A3—liver—atherosclerosis	0.000941	0.021	CbGeAlD
Phenoxybenzamine—ADRA2A—adipose tissue—atherosclerosis	0.000813	0.0181	CbGeAlD
Phenoxybenzamine—Fenoprofen—PTGS2—atherosclerosis	0.0008	0.023	CrCbGaD
Phenoxybenzamine—CALM2—liver—atherosclerosis	0.000799	0.0178	CbGeAlD
Phenoxybenzamine—CALM1—liver—atherosclerosis	0.000795	0.0177	CbGeAlD
Phenoxybenzamine—ADRA1A—liver—atherosclerosis	0.00075	0.0167	CbGeAlD
Phenoxybenzamine—ADRA2C—liver—atherosclerosis	0.000714	0.0159	CbGeAlD
Phenoxybenzamine—Fenoprofen—ALB—atherosclerosis	0.000713	0.0205	CrCbGaD
Phenoxybenzamine—Tamoxifen—ESR1—atherosclerosis	0.000678	0.0195	CrCbGaD
Phenoxybenzamine—Phenylbutazone—PTGS2—atherosclerosis	0.00064	0.0184	CrCbGaD
Phenoxybenzamine—CYP3A4—liver—atherosclerosis	0.000449	0.01	CbGeAlD
Phenoxybenzamine—CALM1—Signaling Pathways—APOE—atherosclerosis	2.94e-05	3.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—LEP—atherosclerosis	2.94e-05	3.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOE—atherosclerosis	2.94e-05	3.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	2.92e-05	3.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	2.91e-05	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—atherosclerosis	2.91e-05	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—atherosclerosis	2.91e-05	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CAV1—atherosclerosis	2.91e-05	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CAV1—atherosclerosis	2.91e-05	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOA1—atherosclerosis	2.9e-05	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—APOA1—atherosclerosis	2.9e-05	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ESR1—atherosclerosis	2.9e-05	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1B—atherosclerosis	2.89e-05	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1B—atherosclerosis	2.89e-05	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.89e-05	3.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	2.89e-05	3.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	2.88e-05	3.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	2.87e-05	3.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTGS2—atherosclerosis	2.87e-05	3.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTGS2—atherosclerosis	2.87e-05	3.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—F2—atherosclerosis	2.86e-05	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ALB—atherosclerosis	2.84e-05	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—INS—atherosclerosis	2.84e-05	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	2.84e-05	3.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	2.83e-05	3.75e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	2.81e-05	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	2.81e-05	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ESR1—atherosclerosis	2.8e-05	3.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ESR1—atherosclerosis	2.8e-05	3.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	2.8e-05	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—NFKB1—atherosclerosis	2.79e-05	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	2.78e-05	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—AKT1—atherosclerosis	2.78e-05	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	2.77e-05	3.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—F2—atherosclerosis	2.77e-05	3.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—F2—atherosclerosis	2.77e-05	3.67e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—AKT1—atherosclerosis	2.76e-05	3.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ALB—atherosclerosis	2.75e-05	3.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ALB—atherosclerosis	2.75e-05	3.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	2.75e-05	3.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—MAPK8—atherosclerosis	2.74e-05	3.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CG—atherosclerosis	2.74e-05	3.63e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—atherosclerosis	2.73e-05	3.63e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTGS2—atherosclerosis	2.73e-05	3.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	2.72e-05	3.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—NOS3—atherosclerosis	2.72e-05	3.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—NFKB1—atherosclerosis	2.7e-05	3.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—NFKB1—atherosclerosis	2.7e-05	3.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—AKT1—atherosclerosis	2.68e-05	3.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—AKT1—atherosclerosis	2.68e-05	3.56e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	2.68e-05	3.56e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	2.68e-05	3.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—AKT1—atherosclerosis	2.66e-05	3.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MAPK8—atherosclerosis	2.65e-05	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MAPK8—atherosclerosis	2.65e-05	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	2.65e-05	3.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	2.65e-05	3.51e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	2.63e-05	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—NOS3—atherosclerosis	2.63e-05	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—NOS3—atherosclerosis	2.63e-05	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	2.63e-05	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	2.62e-05	3.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	2.62e-05	3.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.61e-05	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	2.61e-05	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP9—atherosclerosis	2.6e-05	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	2.59e-05	3.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—INS—atherosclerosis	2.59e-05	3.44e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	2.59e-05	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	2.59e-05	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—AKT1—atherosclerosis	2.58e-05	3.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—AKT1—atherosclerosis	2.58e-05	3.42e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.58e-05	3.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	2.57e-05	3.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	2.56e-05	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	2.56e-05	3.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL2—atherosclerosis	2.55e-05	3.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.55e-05	3.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	2.54e-05	3.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	2.54e-05	3.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	2.53e-05	3.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	2.52e-05	3.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—STAT3—atherosclerosis	2.51e-05	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—INS—atherosclerosis	2.51e-05	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—INS—atherosclerosis	2.51e-05	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF1—atherosclerosis	2.51e-05	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.49e-05	3.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTGS2—atherosclerosis	2.49e-05	3.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	2.48e-05	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL2—atherosclerosis	2.47e-05	3.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL2—atherosclerosis	2.47e-05	3.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.46e-05	3.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	2.43e-05	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—STAT3—atherosclerosis	2.43e-05	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—STAT3—atherosclerosis	2.43e-05	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF1—atherosclerosis	2.43e-05	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF1—atherosclerosis	2.43e-05	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	2.42e-05	3.21e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTGS2—atherosclerosis	2.41e-05	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTGS2—atherosclerosis	2.41e-05	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	2.41e-05	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	2.4e-05	3.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—MAPK3—atherosclerosis	2.4e-05	3.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	2.39e-05	3.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	2.39e-05	3.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	2.38e-05	3.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	2.38e-05	3.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	2.37e-05	3.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	2.36e-05	3.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	2.35e-05	3.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	2.34e-05	3.11e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	2.34e-05	3.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MAPK3—atherosclerosis	2.32e-05	3.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MAPK3—atherosclerosis	2.32e-05	3.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—STAT3—atherosclerosis	2.32e-05	3.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—STAT3—atherosclerosis	2.31e-05	3.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	2.3e-05	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	2.3e-05	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	2.3e-05	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NOS3—atherosclerosis	2.27e-05	3.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	2.26e-05	3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—STAT3—atherosclerosis	2.24e-05	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—STAT3—atherosclerosis	2.24e-05	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	2.24e-05	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MAPK3—atherosclerosis	2.21e-05	2.93e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.21e-05	2.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	2.21e-05	2.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	2.21e-05	2.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	2.21e-05	2.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NOS3—atherosclerosis	2.2e-05	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NOS3—atherosclerosis	2.2e-05	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	2.19e-05	2.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	2.17e-05	2.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	2.17e-05	2.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	2.15e-05	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	2.15e-05	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—atherosclerosis	2.15e-05	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	2.14e-05	2.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MAPK3—atherosclerosis	2.14e-05	2.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MAPK3—atherosclerosis	2.14e-05	2.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	2.13e-05	2.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	2.13e-05	2.82e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOB—atherosclerosis	2.12e-05	2.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	2.1e-05	2.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	2.09e-05	2.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	2.09e-05	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	2.09e-05	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—atherosclerosis	2.08e-05	2.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—atherosclerosis	2.08e-05	2.75e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.06e-05	2.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	2.06e-05	2.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	2.03e-05	2.69e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—LPL—atherosclerosis	2.02e-05	2.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL8—atherosclerosis	2.02e-05	2.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	2e-05	2.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	2e-05	2.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.98e-05	2.62e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GPX1—atherosclerosis	1.97e-05	2.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL8—atherosclerosis	1.95e-05	2.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL8—atherosclerosis	1.95e-05	2.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.94e-05	2.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.94e-05	2.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.93e-05	2.56e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CD36—atherosclerosis	1.92e-05	2.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—atherosclerosis	1.92e-05	2.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.91e-05	2.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—atherosclerosis	1.85e-05	2.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—atherosclerosis	1.85e-05	2.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.83e-05	2.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—atherosclerosis	1.82e-05	2.42e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.82e-05	2.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.81e-05	2.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NFKB1—atherosclerosis	1.8e-05	2.39e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.79e-05	2.38e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.79e-05	2.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.78e-05	2.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK8—atherosclerosis	1.77e-05	2.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.77e-05	2.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—atherosclerosis	1.77e-05	2.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—atherosclerosis	1.76e-05	2.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—atherosclerosis	1.76e-05	2.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—atherosclerosis	1.75e-05	2.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NFKB1—atherosclerosis	1.75e-05	2.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NFKB1—atherosclerosis	1.75e-05	2.32e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—atherosclerosis	1.73e-05	2.3e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AGT—atherosclerosis	1.73e-05	2.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK8—atherosclerosis	1.72e-05	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK8—atherosclerosis	1.72e-05	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—atherosclerosis	1.71e-05	2.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—atherosclerosis	1.71e-05	2.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.7e-05	2.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—atherosclerosis	1.69e-05	2.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—atherosclerosis	1.69e-05	2.25e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOE—atherosclerosis	1.69e-05	2.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—atherosclerosis	1.69e-05	2.24e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.68e-05	2.23e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.68e-05	2.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	1.67e-05	2.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.65e-05	2.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—atherosclerosis	1.64e-05	2.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.64e-05	2.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STAT3—atherosclerosis	1.62e-05	2.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—atherosclerosis	1.62e-05	2.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—atherosclerosis	1.62e-05	2.14e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—atherosclerosis	1.62e-05	2.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—atherosclerosis	1.62e-05	2.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—atherosclerosis	1.58e-05	2.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—atherosclerosis	1.58e-05	2.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STAT3—atherosclerosis	1.57e-05	2.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STAT3—atherosclerosis	1.57e-05	2.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—atherosclerosis	1.56e-05	2.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—atherosclerosis	1.56e-05	2.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—atherosclerosis	1.56e-05	2.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—atherosclerosis	1.56e-05	2.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK3—atherosclerosis	1.55e-05	2.05e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.53e-05	2.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.53e-05	2.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.51e-05	2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.5e-05	2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—atherosclerosis	1.5e-05	1.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK3—atherosclerosis	1.5e-05	1.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK3—atherosclerosis	1.5e-05	1.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—atherosclerosis	1.49e-05	1.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—atherosclerosis	1.49e-05	1.98e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.48e-05	1.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—atherosclerosis	1.45e-05	1.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—atherosclerosis	1.45e-05	1.93e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—INS—atherosclerosis	1.45e-05	1.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—atherosclerosis	1.44e-05	1.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—atherosclerosis	1.44e-05	1.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.41e-05	1.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.39e-05	1.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.37e-05	1.82e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.34e-05	1.77e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—atherosclerosis	1.33e-05	1.76e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.27e-05	1.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—atherosclerosis	1.25e-05	1.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.24e-05	1.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.23e-05	1.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—atherosclerosis	1.21e-05	1.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—atherosclerosis	1.21e-05	1.6e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.16e-05	1.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.15e-05	1.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—atherosclerosis	1.13e-05	1.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—atherosclerosis	1.1e-05	1.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—atherosclerosis	1.1e-05	1.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—atherosclerosis	1.04e-05	1.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—atherosclerosis	1.01e-05	1.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—atherosclerosis	1.01e-05	1.34e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—atherosclerosis	5.84e-06	7.74e-06	CbGpPWpGaD
